Following severe injury, not just the skin but also the subcutis may be destroyed. Consequently, the developing scar can become adherent to underlying structures. Reconstruction of the subcutis can be achieved by autologous fat grafting. Our aim was to evaluate the long-term scar outcome after single-treatment autologous fat grafting using a comprehensive scar evaluation protocol. Scar assessment was performed preoperatively in 40 patients. A 12-month follow-up assessment was performed in 36 patients, using the Cutometer, the Patient and Observer Scar Assessment Scale, and DSM II ColorMeter. The Cutometer parameters elasticity and maximal extension improved with 28 and 22% (both p < 0.001), respectively. Nearly all scores of the scar assessment scale decreased significantly, which corresponds to improved scar quality. In addition, the mean melanin score was ameliorated over time. Thus, we demonstrated the sustainable effectiveness of single-treatment autologous fat grafting in adherent scars, indicated by improved pliability, and overall scar quality.
Over the last decades, the treatment of severely burned patients has improved considerably. However, scarring remains a significant challenge. Scars are not only apparent after burns, but also after other severe injuries such as necrotizing fasciitis or degloving. Injuries severe enough to affect the subcutis destroy the important functional sliding layer between the resulting scar and underlying structures (i.e., muscles, tendons, bone tissue). This ultimately leads to stiff and adherent scars that may limit the affected body part's range of motion. 1 In this case, the only available option to partially reconstruct the subcutis is autologous fat grafting, whereby several layers of fat are injected to generate a sliding system between the scar and the underlying structures.
Recently, we demonstrated the short-term effectiveness (i.e., 3 months follow-up) of single-treatment autologous fat grafting in adherent scars using a comprehensive scar evaluation protocol. 2 Here, we report on the long-term scar outcomes (i.e., 12 months postoperatively) of autologous fat grafting. To our knowledge, this is the first large case-series that provides these data in this rapidly developing field.
MATERIALS AND METHODS

Study design and patients
A prospective study with intraindividual follow-up was performed in 40 consecutive adult patients with adherent scars caused by either burns, necrotizing fasciitis, degloving injury, or other trauma. Scar evaluation was performed within 24 hours preoperatively and at 12 months postoperatively. A concise description of the scar evaluation protocol, fat grafting procedure, and statistics is provided below. More detailed information can be found in our publication on the short-term results. 2 The regional medical ethics committee approved the study protocol and decided the study did not fall under the scope of the Medical Research Involving Human Subjects Act (registration number M014-011). However, in light of the Declaration of Helsinki, written informed consent was obtained from all patients.
Scar evaluation
The primary outcome parameter was scar pliability, measured objectively using the Cutometer Skin Elasticity Meter 575 (Courage and Khazaka GmbH, Cologne, Germany). We used two Cutometer parameters that have previously been shown to be the most reliable: elasticity and maximal extension. 3 Scar color was evaluated using the objective DSM II ColorMeter (Cortex Technology, Hadsund, Denmark). 4 Color results were expressed as the absolute difference between healthy skin and scar tissue. The objective pliability and color measurements were performed on five locations following a standardized algorithm applied in previous clinical studies. 5 The average score of these five measurements was used.
In addition, the entire scar area was subjected to the Patient and Observer Scar Assessment Scale (POSAS) by the patient and two observers (www.posas.org). 6 The scores assessed by the observers were averaged to minimize potential bias and obtain the most reliable results. The questionnaire consisted of two separate six-item scales both scored on a 10-point rating scale. A lower score correlates with a better scar; 1 resembles normal skin and 10 the worst imaginable scar.
Autologous fat grafting
Fat grafting was performed following the Coleman technique. 7 First, tumescence solution (500 ml of 0.9% sodium chloride, 20 ml of 1% Xyloca€ ıne, and 1 : 200,000 IU adrenalin) was applied to the donor site. Subsequently, fat tissue was obtained using a 3-mm two-hole Coleman harvesting cannula attached to a 10-ml Luer-Lock syringe. Manual suction was performed with gradual negative pressure.
The syringes filled with fat were centrifuged at 3,000 r.p.m. (1,200g ) for 3 minutes (MediLite Centrifuge; Thermo Fisher Scientific Inc., Waltham, MA), separating the usable fatty tissue from an upper oil layer and bottom layer of blood and tumescent solution. The resulting fat was transferred to a 1-ml syringe for small scars, or reserved in the 10-ml Luer-Lock syringe to be used for larger scar surfaces.
Through 2-mm incisions at the border of the scar, a 16-gauge V-shape needle was inserted, and advanced into the appropriate plane. When the needle was retracted, the prepared fat tissue was simultaneously injected through the same needle. The incisions were closed using resorbable material [e.g., Vicryl Rapide (Ethicon, Inc., Somerville, NJ) or Histoacryl (TissueSeal, Ann Arbor, MI)].
Statistics
We performed an a priori power analysis (G*Power 3 version 3.1.9.2), estimating a sample size of 34 patients. We anticipated a maximum dropout rate of 10% during follow-up, and therefore included a total of 40 patients. Analyses were performed with SPSS Statistics, version 21.0 (IBM Corp., Armonk, NY). All reported p-values are two tailed and p < 0.05 was considered statistically significant.
RESULTS
Thirty-six out of 40 patients completed the 12 months follow-up period. Measurements were performed on average at 13.2 months (SD 2.2) postoperatively. The mean patient age at surgery was 45.0 (15.3) years, and the mean scar age was 17.9 (16.4) years. Scar etiology was classified as follows: 22 burns (55.0%), 3 necrotizing fasciitis (7.5%), 8 degloving injury (20.0%), and 7 other trauma (17.5%).
The Cutometer parameters elasticity and maximal extension improved 28% (p < 0.001, Paired samples t test) and 22% (p < 0.001), respectively. Table 1 presents the corresponding absolute values of the Cutometer parameters over time and the 95% confidence intervals of the difference.
Total POSAS scores (i.e., the average score of six items) and nearly all single item scores for both the observer and patient further decreased at 12 months follow-up compared to the short-term follow-up (Table 2) , corresponding to an additional improved scar quality.
At the short-term follow-up, DSM II Color measurements were practically unaltered compared to the preoperative values, but at 12 months follow-up, the mean melanin score decreased from 6.4 (95% CI 4.8-7.9) preoperatively to 4.5 (95% CI 2.0-7.1), reflecting a smaller difference between the scar's pigmentation and healthy skin (p 5 0.091, Paired samples t test). The mean erythema score slightly decreased from 3.9 (95% CI 3.0-4.7) preoperatively to 3.4 (95% CI 2.4-4.4) at 12 months follow-up (p 5 0.400).
DISCUSSION
Our results indicate that single-treatment autologous fat grafting provides sustainable improvement in the quality of adherent scars. The lasting enhancement of pliability demonstrates the benefits of the use of fat grafting for patients suffering from scar stiffness where friction occurs between the scar and underlying structures. To our knowledge, this is the first clinical study assessing the long-term effect of autologous fat grafting on functional scar parameters using a comprehensive scar evaluation protocol. In addition to objective pliability, subjective (POSAS) pliability also improved significantly. Immunohistochemical results from existing literature may explain this; these studies reported new collagen deposition and increased vascularization after autologous fat grafting. [8] [9] [10] Moreover, Bruno et al. and Piccolo et al. showed an increased amount of elastic fibers at the dermopapillary layer, 11, 12 which may also account for an improved dermal quality. The effects of scar maturation over time cannot be completely excluded, however, all scars in the current study were mature (mean age 17.9 years) and appeared stable over a long time prior to treatment.
In contrast to the short-term follow-up, we now found ameliorated melanin values as measured by the DSM II ColorMeter. Findings by Bruno et al., who showed a reduction in melanogenic activity after fat grafting indicated by a significant decrease in S100-positive cellular count, support these results. 11 Objective erythema values only slightly decreased over time. However, this finding was expected because the scars did not show signs of immaturity preoperatively. Using subjective assessment, our study patients also reported an improved scar color, which is reflected by the lowered POSAS score on the item color (p 5 0.021) at 12 months follow-up.
It seems that additional tissue changes and/or adipocyte regeneration have occurred at 12 months follow-up, as it is known that not all injected fat survives. 13 The exact equilibrium between the amount of fat and the regenerative capacities of adipose derived stem cells (ADSCs) over time is unknown, but it is presumed that the amount of fat decreases, while the regenerating effect increases between 3 and 12 months follow-up. 11, 14 The mechanism of fat graft survival, and whether survival can be improved by enriching grafts with high-dose ex vivo expanded ADSCs 15 are important questions that require further exploration. Furthermore, only few RCTs (comparing fat grafting vs. saline injection) have been performed in the highly emerging field of autologous fat grafting. Therefore, it is still unclear if the functional scar quality also improves when only adhesiolysis and saline injection is performed. Although the potential remodeling effect by ADSCs will not be present without fat grafting and scars will probably become adherent again, there is often debate on this topic. In future research, it would also be useful to focus on the patient's mobility and functional improvement (where possible) using questionnaires such as the Quick-DASH (Disabilities of Arm, Shoulder and Hand questionnaire) and/or the LLFI (Lower Limb Functional Index). Hence, it is expected that continuing developments and the extension of data by new trials will increasingly foster the use of autologous fat grafting in adherent scars.
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